11 results match your criteria: "South Texas Bone and Joint Institute[Affiliation]"
Reg Anesth Pain Med
January 2019
Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
J Arthroplasty
October 2018
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty
October 2018
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
Background: Tranexamic acid (TXA) is an antifibrinolytic agent commonly used to reduce blood loss in total hip arthroplasty (THA). The purpose of our study was to evaluate the efficacy of TXA in primary THA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Medicine on the use of TXA in primary total joint arthroplasty.
Methods: A search was performed using Ovid-MEDLINE, Embase, Cochrane Reviews, Scopus, and Web of Science databases to identify all publications before July 2017 on TXA in primary THA.
J Arthroplasty
October 2018
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois.
J Arthroplasty
October 2018
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois.
Background: A growing body of published research on tranexamic acid (TXA) suggests that it is effective in reducing blood loss and the risk for transfusion in total knee arthroplasty (TKA). The purpose of this network meta-analysis was to evaluate TXA in primary TKA as the basis for the efficacy recommendations of the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Medicine on the use of TXA in primary total joint arthroplasty.
Methods: We searched Ovid MEDLINE, Embase, Cochrane Reviews, Scopus, and Web of Science databases for publications before July 2017 on TXA in primary total joint arthroplasty.
J Arthroplasty
October 2018
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
Background: Tranexamic acid (TXA) is effective in reducing blood loss in total joint arthroplasty (TJA), but concerns still remain regarding the drug's safety. The purpose of this direct meta-analysis was to evaluate and establish a basis for the safety recommendations of the combined clinical practice guidelines on the use of TXA in primary TJA.
Methods: A search was completed for studies published before July 2017 on TXA in primary TJA.
Curr Rev Musculoskelet Med
March 2018
Shoulder and Elbow Service, Florida Orthopaedic Institute, 13020 N Telecom Pkwy, Tampa, FL, 33637, USA.
Purpose Of Review: The purpose of this review is to discuss the indications for reverse shoulder arthroplasty (RSA) in the treatment of massive rotator cuff tear (MCT), review the reported outcomes in the literature, and outline our approach and surgical technique for treating these patients.
Recent Findings: While RSA remains a successful and well-accepted treatment for cuff tear arthropathy (CTA), management of MCT in the absence of arthritis is controversial. In this particular setting, patients best suited for RSA are elderly, lower-demand individuals with chronic, irreparable MCT, and pseudoparalysis.
J Orthop
March 2017
South Texas Bone and Joint Institute, 5510B Presidio Parkway, Suite 2401, San Antonio, TX 78249, USA.
Introduction: Liposomal bupivacaine has a paucity of data regarding narcotic requirements and hospital length of stay in comparison to other peri-articular injections, specifically in the total hip arthroplasty (THA) population.
Methods: 69 patients who underwent THA by a single surgeon were divided into two cohorts over a 3 year period in this retrospective study comparing narcotic requirements, hospital length of stay and cost. The study group (n = 29) received liposomal bupivacaine whereas a matched control group (n = 40) received a pharmacy-mixed cocktail in peri-articular structures.
Background: Knee osteoarthritis is a disabling disease that costs billions of dollars to treat. Corticosteroid gives varying pain relief and costs $12 per injection, whereas ketorolac costs $2 per injection, per institutional costs. The aim of this study was to compare ketorolac with corticosteroid based on pain relief using patient outcome measures and cost data.
View Article and Find Full Text PDFSurg Technol Int
May 2015
Department of Orthopaedic Surgery, Center for Joint Preservation and Replacement, Rubin Institute for Advanced Orthopedics, Baltimore, Maryland.
The routine use of highly cross-linked ultra-high molecular weight polyethylene (UHMWPE) has remained controversial secondary to the possibility of decreased material properties when compared to conventional UHMWPE. The aim of the present study was to evaluate if thin, sequentially-irradiated, and annealed highly cross-linked UHMWPE tibial inserts would have improved wear properties, while maintaining mechanical integrity, compared to conventional UHMWPE during biomechanical testing under aligned and malaligned conditions. Polyethylene inserts (4.
View Article and Find Full Text PDFTex Med
May 2008
South Texas Bone and Joint Institute, 1219 Corpus Christi, Laredo, TX 78040, USA.
Fall-related injuries in elderly people constitute a major public health problem associated with considerable morbidity and mortality. In 2004, unintentional injuries in adults 65 years and older were the eighth leading cause of death in Texas, and falls accounted for 37.1% of these fatal injuries.
View Article and Find Full Text PDF